SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000898432-04-000377
Filing Date
2004-04-28
Accepted
2004-04-28 17:37:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 bvf_incara-sc13g.txt SC 13G 26262
2 ex-1.htm EX-99 7370
  Complete submission text file 0000898432-04-000377.txt   35712
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address PO BOX 14287 RTP NC 27709-4287
Business Address
INCARA PHARMACEUTICALS CORP (Subject) CIK: 0001261734 (see all company filings)

IRS No.: 561953785 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-79369 | Film No.: 04761759
SIC: 2834 Pharmaceutical Preparations